Nouscom activates Commercial Product License for ProBioGen’s proprietary Vaccine Production Cell Line AGE1.CR.pIX®
Berlin, Germany, April 15, 2021: ProBioGen announced today that Nouscom has activated a commercial product license to ProBioGen's innovative, cell-based vaccine platform..
ProBioGen enters into Agreement with Nobelpharma for Manufacturing Process Development of their Vaccine Project
Berlin, March 24, 2021: ProBioGen AG is delighted to announce the signing of a service agreement for Nobelpharma’s highly relevant vaccine project. Earlier work confirmed already..
ProBioGen licenses GlymaxX® Technology to Sanofi
Enhancement of Target Cell Killing for Innovative Therapies Berlin, March 17, 2021: ProBioGen AG has signed a commercial multi-product license agreement with Sanofi. Under such..
Harbour BioMed and ProBioGen agree on a GlymaxX® License to Fast-Track Cell Line Development Projects
Berlin, Germany and Shanghai, China, February, 2nd, 2021: ProBioGen AG and Harbour BioMed today jointly announced their agreement on a cell line development project and..
ProBioGen licenses GlymaxX® Technology to AbbVie
Berlin, Germany, January 21st, 2021: ProBioGen AG has signed a commercial license agreement with AbbVie for applying ProBioGen’s proprietary GlymaxX® technology to boost the..
ProBioGen Launches New Website to Enhance User Experience and Streamline Access to Expanded Portfolio
Feb 4, 2025
Transgene and ProBioGen Join Forces to Advance Individualized Cancer Vaccine Development
Nov 5, 2024
ModeX Therapeutics Leverages ProBioGen's Expertise for Accelerated COVID-19 Antibody Development
May 29, 2024
ProBioGen and DIOSynVax Partner to Manufacture Groundbreaking Multivalent Vaccine for Hemorrhagic Fever
Mar 27, 2024
ProBioGen Partners with MAPP BIOPHARMACEUTICAL, INC. for Groundbreaking Development of Afucosylated Antibody Against Marburg Virus Disease Using GlymaxX Technology
Mar 13, 2024
GeoVax Secures Multi-Product License for ProBioGen's AGE1.CR.pIX® Suspension Cell Line to Bolster MVA-Based Vaccine Development
Sep 26, 2023
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
Apr 12, 2023
